Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...

The Food and Drug Administration (FDA) has approved Rybrevant Faspro™, a subcutaneous (SC) formulation of amivantamab for all indications approved for the ...

The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...

The FDA has approved the subcutaneous administration of a fixed combination of amivantamab (Rybrevant; Johnson & Johnson) and a recombinant human hyaluronidase for patients with non–small cell lung ...

The FDA approves a new subcutaneous formulation of amivantamab, enhancing treatment for advanced lung cancer with reduced administration time and improved safety.

For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...

Introduction Refractory headache is a common and frequently disabling disorder, affecting 2–12 million patients each year in ...

Pokemon Sword and Shield include a way to see the Individual Values (often shortened to IVs) of a Pokemon just by looking at it in your box. IVs are a set of hidden stats that affect each individual ...

Patients who depend on antibody drugs often spend long hours in infusion centers. These medicines are vital for treating many ...

Tepezza is an intravenous medication that may help treat thyroid eye disease (TED) by addressing immune system activity behind the eyes. Possible side effects of Tepezza include hearing issues, ...

Equine-assisted psychotherapy, sometimes referred to as EAP, EAT, or “equine therapy,” refers to activities with horses that are conducted while being supervised by a mental health professional and a ...